BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38103700)

  • 1. Similarities and differences in peripheral itch and pain pathways in atopic dermatitis.
    Yosipovitch G; Kim B; Luger T; Lerner E; Metz M; Adiri R; Canosa JM; Cha A; Ständer S
    J Allergy Clin Immunol; 2024 Apr; 153(4):904-912. PubMed ID: 38103700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
    Mollanazar NK; Smith PK; Yosipovitch G
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):263-292. PubMed ID: 25931325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.
    Meng J; Li Y; Fischer MJM; Steinhoff M; Chen W; Wang J
    Front Immunol; 2021; 12():696784. PubMed ID: 34276687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms?
    Liu T; Ji RR
    Pflugers Arch; 2013 Dec; 465(12):1671-85. PubMed ID: 23636773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloknesis and hyperknesis-mechanisms, assessment methodology, and clinical implications of itch sensitization.
    Andersen HH; Akiyama T; Nattkemper LA; van Laarhoven A; Elberling J; Yosipovitch G; Arendt-Nielsen L
    Pain; 2018 Jul; 159(7):1185-1197. PubMed ID: 29659469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent studies of cutaneous nociception in atopic and non-atopic subjects.
    Heyer GR; Hornstein OP
    J Dermatol; 1999 Feb; 26(2):77-86. PubMed ID: 10091477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments.
    Wong LS; Wu T; Lee CH
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New mechanism underlying IL-31-induced atopic dermatitis.
    Meng J; Moriyama M; Feld M; Buddenkotte J; Buhl T; Szöllösi A; Zhang J; Miller P; Ghetti A; Fischer M; Reeh PW; Shan C; Wang J; Steinhoff M
    J Allergy Clin Immunol; 2018 May; 141(5):1677-1689.e8. PubMed ID: 29427643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral itch sensitization in atopic dermatitis.
    Tominaga M; Takamori K
    Allergol Int; 2022 Jul; 71(3):265-277. PubMed ID: 35624035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch.
    Wilson SR; Thé L; Batia LM; Beattie K; Katibah GE; McClain SP; Pellegrino M; Estandian DM; Bautista DM
    Cell; 2013 Oct; 155(2):285-95. PubMed ID: 24094650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propionate alleviates itch in murine models of atopic dermatitis by modulating sensory TRP channels of dorsal root ganglion.
    Xu Y; Qiu Z; Gu C; Yu S; Wang S; Li C; Yao X; Li W
    Allergy; 2024 May; 79(5):1271-1290. PubMed ID: 38164798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch.
    Ikoma A; Fartasch M; Heyer G; Miyachi Y; Handwerker H; Schmelz M
    Neurology; 2004 Jan; 62(2):212-7. PubMed ID: 14745056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonhistaminergic and mechanical itch sensitization in atopic dermatitis.
    Andersen HH; Elberling J; Sølvsten H; Yosipovitch G; Arendt-Nielsen L
    Pain; 2017 Sep; 158(9):1780-1791. PubMed ID: 28614190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for itch and disease severity in atopic dermatitis.
    Lee CH; Yu HS
    Curr Probl Dermatol; 2011; 41():136-148. PubMed ID: 21576954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-20 promotes cutaneous inflammation and peripheral itch sensation in atopic dermatitis.
    Lu Z; Xiao S; Chen W; Zhu R; Yang H; Steinhoff M; Li Y; Cheng W; Yan X; Li L; Xue S; Larkin C; Zhang W; Fan Q; Wang R; Wang J; Meng J
    FASEB J; 2022 Jun; 36(6):e22334. PubMed ID: 35486004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Understanding of Pathophysiological Mechanisms of Atopic Dermatitis: Interactions among Skin Barrier Dysfunction, Immune Abnormalities and Pruritus.
    Fujii M
    Biol Pharm Bull; 2020; 43(1):12-19. PubMed ID: 31902917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous Components Leading to Pruritus, Pain, and Neurosensitivity in Atopic Dermatitis: A Narrative Review.
    Ständer S; Luger T; Kim B; Lerner E; Metz M; Adiri R; Canosa JM; Cha A; Yosipovitch G
    Dermatol Ther (Heidelb); 2024 Jan; 14(1):45-57. PubMed ID: 38182845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-31-generating network in atopic dermatitis comprising macrophages, basophils, thymic stromal lymphopoietin, and periostin.
    Hashimoto T; Yokozeki H; Karasuyama H; Satoh T
    J Allergy Clin Immunol; 2023 Mar; 151(3):737-746.e6. PubMed ID: 36410530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Transient Receptor Potential (TRP) Channels, Mas-Related G-Protein-Coupled Receptors (Mrgprs), and Protease-Activated Receptors (PARs) to Relieve Itch.
    Tsagareli MG; Follansbee T; Iodi Carstens M; Carstens E
    Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics.
    Kwatra SG; Misery L; Clibborn C; Steinhoff M
    Clin Transl Immunology; 2022; 11(5):e1390. PubMed ID: 35582626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.